Artículos del autor

solaci

Events

Latam SOLACI-EuroPCR Session

Once more, SOLACI is proud to participate at one of the most important interventional cardiology meetings in...
solaci -
Antiplatelet

The First Antidote Against Ticagrelor Is a Rapid-Acting, Extended Effect Agent in Preliminary Results

This study attempts to test drug PB2452 for use in cases of catastrophic bleeding and, then, its...
solaci -
Aorta

Patients: What They Really Want to Know about Their Disease

When we decide that 30-day mortality to repair an abdominal aortic aneurysm (AAA) is at least twice...
solaci -
Structural heart disease

TAVR Still Gaining Ground Among Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has become the standard of care for patients with severe aortic stenosis...
solaci -
Other

Is Alcohol Good, Bad, or Neutral for Cardiovascular Health?

In the 2018 Guidelines on Hypertension, commandment no. 6 states that we should make lifestyle interventions such...
solaci -
Mitral valve

MitraClip in the “Real World”

Courtesy of Dr. Carlos Fava. Mitral regurgitation (MR) is the most frequent valvulopathy in Europe and US, affecting...
solaci -
Institutional News

Submit a Case for the TCT International Fellow Session

The TCT 2019 Congress, one of the most important interventional cardiology events worldwide, will take place from September...
solaci -
Coronary disease

Surprising EXCEL Outcomes in Diabetics with Main Left Stenosis

This study especially designed to compare PCI vs. CABG in patients with left main coronary artery disease...
solaci -